Health
Genmab's stock rises on cancer data, while Iovance, Coherus tumble
Cancer trial news drove a number of stock moves in both directions over the past 24 hours. Here's a summary of key results and their impact: Genmab shares rise on head and neck cancer data: ...
- Published
- (2 h ago)
- Outlet
- Endpoints News
- Section
- Health
- Length here
- Headline and 36-word snippet. The full article is at the source.
More from Endpoints News and around the same time
UK lands £500M in biopharma pledges; Teva to shutter New Jersey sitePlus, news about Esteve and Regeneron. UK pulls in £500M investment: As part of the UK’s Autumn budget, Vertex Pharmaceuticals said it will invest over £300 million in a new R&;D site in Oxford, UK ...Ono's five failures; Lenz and Molecular Partners to lay off staffPlus, news about GSK, Ascletis, BioMarin, Rigerna and Hisun. Ono Pharma’s endocannabinoid modulator flunks five trials: The biotech’s ONO-1110 did not meet the primary endpoint in five separate Phase 2 studies ...Personal AI agents are coming to healthcareIn September, I reported on the phenomenon of big tech companies and startups standing up capabilities to ingest people’s medical records and other health data, so they could interpret the ...Anthropic pitches 'age of miracles,' gives biopharma research updateA day after publishing the paperwork for what could be the business world’s largest-ever IPO, Anthropic released the most detailed look yet at its biopharma ambitions, including the possibility of bringing ...Lilly again far surpasses revenue expectationsEli Lilly once again dominated revenue expectations, blowing past Wall Street's estimates by about $2 billion. The world's most valuable healthcare company posted $24.4 billion in third-quarter revenue, aided by what ...Dren Bio raises $350M to get blood cancer drug onto market in 2027Dren Bio has raised $350 million, hoping to get its lead blood cancer drug onto the market by the end of 2027, the California drug developer exclusively told Endpoints News. The Thursday morning haul will ...This page holds the headline and a short snippet as published by Endpoints News, whose feed they came from. The story itself, the photography and the rights stay with them, and the button above goes straight to their site. We keep this page so the headline has a stable address and a record of when it ran.
